Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on “Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18, 185”.

This review article discusses BPC 157, a synthetic peptide, and its proposed mechanisms of action related to angiogenesis and nitric oxide regulation, responding to previous literature on the peptide’s multifunctional properties and potential medical applications. The authors address how BPC 157 may modulate the balance between protective and damaging actions of nitric oxide while promoting blood vessel formation. The evidence level is a review of existing literature rather than new primary research (review article).

Read more on Pharmaceuticals (Basel, Switzerland) →

Scroll to Top